Product Information

TELMISARTAN-AMLODIPINE 40-5 MG is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $3.2466 per EA under NDC 00378107593. Its NADAC has been published 187 times since Apr 19, 2023.

FDA first approved this application on Aug 26, 2014.

TELMISARTAN-AMLODIPINE 40-5 MG

telmisartan and amlodipine
$3.2466per EA

Strength

5; 40 mg/1; mg/1

NDC

00378107593

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA202516

FDA Approved

8/26/2014

On Market Since

9/19/2014

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines

Price Statistics

The NADAC for TELMISARTAN-AMLODIPINE 40-5 MG has been published 187 times since Apr 19, 2023, and over the history we have for it it has declined 16.5%. The table below summarizes its recorded NADAC range and movement.

Current price$3.2466 per EA
All-time high$3.8874 (Jun 14, 2023)
All-time low$2.1556 (Jan 22, 2025)
52-week high$3.2466
52-week low$2.5031
Median price$2.7273
Average price$2.7523
Largest weekly change-31.8% (Jun 21, 2023)
Weeks tracked187
Tracking sinceApr 19, 2023

Price History

1W

0.0%

1M

+1.7%

3M

+7.5%

6M

+19.9%

1Y

+16.3%

3Y

+13.7%

5Y

N/A

All

-16.5%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the telmisartan and amlodipine market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TELMISARTAN-AMLODIPINE 40-5 MG?

The current National Average Drug Acquisition Cost (NADAC) for TELMISARTAN-AMLODIPINE 40-5 MG, manufactured by Mylan Pharmaceuticals Inc., is $3.2466 per EA (NDC 00378107593), effective Nov 11, 2026.

How has the price of TELMISARTAN-AMLODIPINE 40-5 MG changed over time?

Over the history we have for it, the NADAC for TELMISARTAN-AMLODIPINE 40-5 MG has declined 16.5%. It has been tracked across 187 weekly CMS publications since Apr 19, 2023.

What are the highest and lowest recorded NADAC prices for TELMISARTAN-AMLODIPINE 40-5 MG?

Since Apr 19, 2023, the NADAC for TELMISARTAN-AMLODIPINE 40-5 MG has ranged from a low of $2.1556 (Jan 22, 2025) to a high of $3.8874 (Jun 14, 2023), with a median of $2.7273 per EA.

Are there cheaper alternatives to TELMISARTAN-AMLODIPINE 40-5 MG?

No other NADAC-published product currently shares the active ingredient and strength of TELMISARTAN-AMLODIPINE 40-5 MG in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures TELMISARTAN-AMLODIPINE 40-5 MG?

TELMISARTAN-AMLODIPINE 40-5 MG (NDC 00378107593) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.